ArticleCureus2026
Recurrent Hyperparathyroidism Due to Hyperactive Ectopic Intrathymic Parathyroid Gland 20 Years After Parathyroidectomy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary hyperparathyroidism is most commonly caused by a single adenoma, with multiglandular disease accounting for a smaller proportion of cases. A recurrent hyperparathyroidism decades after prior parathyroidectomy is uncommon and often presents with nonspecific multisystem symptoms that delay diagnosis. Ectopic parathyroid tissue, particularly in intrathymic or retrosternal locations, represents a challenging but important cause of persistent or recurrent disease. A 43‑year‑old woman with a history of three‑gland parathyroidectomy 20 years earlier presented with a year of progressive fatigue, generalized weakness, recurrent colicky abdominal pain, persistent nausea, and an 8‑kg unintentional weight loss. She also reported diffuse arthralgia, proximal myalgia, and significant neuropsychiatric symptoms, prompting psychiatric evaluation. Laboratory studies revealed hypercalcemia (10.9 mg/dl), markedly elevated parathyroid hormone (PTH) (1235 pg/ml), hypophosphatemia, vitamin D insufficiency, and hypomagnesemia. Imaging demonstrated destructive maxillofacial lesions, multiple sclerotic skeletal lesions, and persistent technetium‑99m sestamibi uptake in the mediastinum, consistent with an ectopic retrosternal parathyroid gland. The patient underwent thoracic surgical excision of the mass, with intraoperative PTH drop from 1235 pg/ml to 371 pg/ml. Histopathology confirmed an intrathymic parathyroid gland with hyperplasia and a dominant oxyphil pseudo‑adenomatous nodule. Following surgical excision, the patient experienced rapid biochemical normalization and complete resolution of her gastrointestinal, musculoskeletal, and neuropsychiatric symptoms. Serial outpatient follow‑up demonstrated the sustained normalization of calcium and PTH levels. This case highlights the importance of considering an ectopic intrathymic parathyroid tissue as a cause of late recurrent hyperparathyroidism, even decades after prior surgery. Persistent multisystem symptoms in patients with a history of parathyroidectomy warrant thorough biochemical evaluation and advanced imaging to ensure timely localization and definitive management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.